MedTrace Logo

Zonisamide in the Treatment of Essential Tremor

NCT00616343 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2014-07-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if Zonisamide is effective in reducing tremors in patients with Essential Tremor.

Conditions

Interventions

DRUG

Zonisamide

100mg tablets once a day for two weeks, then increased to 200mg qhs for two weeks.

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • David M Swope, MD · Loma Linda University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2012-10-31
Completion
2012-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00616343 on ClinicalTrials.gov